What matters in saving more lives? Production
Charity begins at home, especially in safeguarding Americans from COVID-19. But Americans have a long, praiseworthy record of having big hearts, and now should be no exception to that.
Efforts to develop new medicines to treat the symptoms of COVID-19 and to develop vaccines against it have proceeded at a feverish pace. That is true in other developed countries as well as here in the United States.
Gratifying success has been reported, both here and in Europe. Still, experts predict vaccines will not be available until early 2021. Once they are put in production, supplies will be limited.
That worries many people in countries without their own research, development and health care manufacturing capabilities. It has been suggested lives will be lost because nations such as ours will hoard vaccines, refusing to share them with the rest of the world.
But that need not be the case. We are Americans, after all. Historians are aware that for well over a century, our efforts to save others in the world from famine, disease and disaster have set new standards for the rest of the world. Beyond any reasonable doubt, what our nation has done has saved hundreds of millions of lives.
So it can — and should — be again.
What is needed is a determination to develop effective vaccines at top speed, then manufacture them in quantities adequate to serve both Americans and others.